Design and synthesis of bioactive compounds

Bioorg Med Chem. 2017 Oct 1;25(19):5031. doi: 10.1016/j.bmc.2017.09.020.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / chemical synthesis
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cell Cycle Proteins / antagonists & inhibitors
  • Cell Cycle Proteins / metabolism
  • Central Nervous System Diseases / drug therapy*
  • Communicable Diseases / drug therapy*
  • Drug Design*
  • Humans
  • Neoplasms / drug therapy*
  • Polo-Like Kinase 1
  • Proteasome Endopeptidase Complex / drug effects
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Proto-Oncogene Proteins / metabolism
  • STAT Transcription Factors / antagonists & inhibitors
  • Small Molecule Libraries / chemical synthesis
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Cell Cycle Proteins
  • Proto-Oncogene Proteins
  • STAT Transcription Factors
  • Small Molecule Libraries
  • Protein Serine-Threonine Kinases
  • Proteasome Endopeptidase Complex